Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series.

Pietro CrispinoRaffaella MaroccoDaniela Di TrentoGloria GuariscoBlerta KertushaAnna CarraroSara CorazzaCristina PaneLuciano Di TroiaCosimo Del BorgoMiriam Lichtner

Published in: Microorganisms (2023)

Pregnant COVID-19 patients receiving sotrovimab obtained better clinical outcomes. Pregnancy or neonatal complications were not observed after monoclonal treatment, confirming the safety and tolerability of these drugs in pregnant women.

Keyphrases

pregnant women
coronavirus disease
sars cov
pregnancy outcomes
open label
respiratory syndrome coronavirus
risk factors
preterm birth
multiple myeloma
randomized controlled trial
clinical trial
placebo controlled